$20 million Commonwealth Foundation for Cancer Research gift to expand collaborative cancer research
Gift will augment the Bridge Project, a collaborative project between the Dana-Farber/Harvard Cancer Center and MIT's Koch Institute.
Koch Institute
Biologists unravel drug-resistance mechanism in tumor cells
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.
Using ultrasound to improve drug delivery
New approach could aid in treatment of inflammatory bowel disease.
Quantum physics meets genetic engineering
Researchers use engineered viruses to provide quantum-based enhancement of energy transport.
Biologists find unexpected role for amyloid-forming protein
Yeast protein could offer clues to how Alzheimer’s plaques form in the brain.
How flu viruses gain the ability to spread
New study reveals the soft palate is a key site for evolution of airborne transmissibility.
Real-time data for cancer therapy
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Identifying a key growth factor in cell proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
New material opens possibilities for super-long-acting pills
A pH-responsive polymer gel could create swallowable devices, including capsules for ultra-long drug delivery.
New study shows how nanoparticles can clean up environmental pollutants
Nanomaterials and UV light can “trap” chemicals for easy removal from soil and water.
Paula Hammond named head of Department of Chemical Engineering
An MIT faculty member since 1995, Hammond succeeds Klavs Jensen as ChemE department head.
Major step for implantable drug-delivery device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Glenn Foundation gift to MIT to fund multiple research initiatives on how we age
New center will incorporate research on the study of aging in the Department of Biology, Picower Institute for Learning and Memory, and David H. Koch Institute for Integrative Cancer Research.
Seeking rare cells
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.